RWD62 Dupixam: An SNDS (SYSTÈME NATIONAL DES DONNÉES DE SANTÉ) Study to Characterize Patients Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis in France
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.2779
https://www.valueinhealthjournal.com/article/S1098-3015(23)05909-0/fulltext
Section Title :
Section Order :
12115
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05909-0&doi=10.1016/j.jval.2023.09.2779